Who Was in the Room in 2025?
Get an exclusive preview of the leading experts, pioneering companies, and top decision-makers shaping the future of targeted radiopharmaceuticals.
By downloading the 2025 Blind Attendee List, you will discover:
The job titles of key attendees
The companies already confirmed
The caliber of industry leaders driving discussions
Explore the Agenda
Discover how leading scientists and clinicians in TRP and radioligand therapy are redefining every stage of development - from target discovery and validation to isotope selection and commercialization strategy. Gain insight into the approaches shaping the next generation of radiopharmaceutical therapies and accelerating their path to the clinic.
Partner With Us
Engage directly with key decision-makers across imaging, radiochemistry, isotope development and more, who are actively seeking collaborations. Explore opportunities to accelerate the development of safer, more effective radiopharmaceuticals and contribute to projects that move quickly from concept to clinical application.
Join TRP Experts
Network with over 260 radiochemists, biologists, clinicians, and R&D leaders who are shaping the full RLT pipeline. Share expertise, exchange ideas, and collaborate across discovery, preclinical development, and clinical translation to advance therapies that can make a real impact for patients.